speb/financial-data huggingface dataset:
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 149708000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 72587560.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3602318000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3469879000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 74788000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.29
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 8434157000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4419047000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 3069409000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3608916000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2503043000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4825241000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3476810000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 912628000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 38831000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1044733000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 720659000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2774244000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 73253086.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.62
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1854981000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 54002000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 54002000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 73253086.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.62
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — EBIT: 221054000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — EBITDA: 275056000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 919263000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 58163000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 58163000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 118671000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -58163000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -58163000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 275056000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 118670000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Operating Income: 198604000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2774244000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 22447000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 497874000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 162891000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1854981000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 54002000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 44220000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2575640000.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2900919000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 794886000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — +Total Revenue: 11596609000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3176061000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1336680000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1336680000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2815448000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2815448000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 61685000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 61685000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 73517702.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 75116850.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Basic EPS: 10.79
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.73
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 151505000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -784341000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 65203000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 65203000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 222278000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 222278000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -36292000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -384501000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 103780000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 33023000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Payable: 60375000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -267799000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -446929000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 70772000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Common Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 362938000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -36292000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 3923452000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3923452000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 312997000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 312997000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 7682940000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2096775000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5284580000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5284580000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Current Debt: 2261133000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 2261133000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2261133000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2261133000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4071460000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4071460000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 28121000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 28121000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Depreciation: 214937000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 214937000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 214937000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 57866000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 214937000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 57866000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 73517702.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 75116850.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Diluted EPS: 10.79
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.73
INDOAMIN.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 205069000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 634000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — EBIT: 1298439000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — EBIT: 343373000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — EBITDA: 1513376000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — EBITDA: 401239000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — End Cash Position: 222277000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -11559000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 3615000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -60076000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -59442000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 125784000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 125784000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 3433230000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3433230000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Gross Profit: 3913669000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1079286000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Interest Expense: 237373000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 56641000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 237373000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 56641000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -237373000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 12488000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Inventory: 1782640000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1782640000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 7032235000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7032235000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -705625000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 61685000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 61685000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 847650000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 847650000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 847650000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 847650000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 19495000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 19495000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 14324000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 14324000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Net Debt: 3043580000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 3043580000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 12080000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income: 205069000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 205069000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 793255000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 205068000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 205069000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 205069000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1047851000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 205069000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Interest Income: -237373000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -56641000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1513000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 262106000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 61275000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -237373000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -56641000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Net PPE: 3433230000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 3433230000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -717233000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 200831000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 3797668000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3797668000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 94224000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 94224000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1513376000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 401239000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Normalized Income: 793256000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 205069000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 787956000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Operating Income: 1012750000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Operating Income: 284400000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Operating Revenue: 11596609000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3176061000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 72587560.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 72587560.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 461580000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 461580000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 403051000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 403051000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 3560514000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 3560514000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 42493000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 42493000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 238100000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 54513000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 54513000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 285689000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 58973000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2030388000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 561320000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3120233000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3120233000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 2634000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2634000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 157075000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 157075000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Payables: 1379155000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1379155000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Pretax Income: 1061066000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 286732000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -784341000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 7682940000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2096775000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 214937000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 57866000.00
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 67108000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Share Issued: 72587560.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 72587560.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 3923452000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3923452000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 3797668000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3797668000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Tax Provision: 267811000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 81664000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.28
INDOAMIN.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -218007000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Assets: 8974563000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 8974563000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 4771102000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4771102000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Debt: 3108783000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 3108783000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 3937776000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3937776000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Total Expenses: 10583859000.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2891661000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 5036787000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5036787000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3675212000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3675212000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 965327000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 965327000.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 42475000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 42475000.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1213120000.00
INDOAMIN.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1213120000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -168747000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2720000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 32090000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Basic EPS: 11.33
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 111296000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 329064000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 29515000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 32090000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Diluted EPS: 11.33
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 2389000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 2964000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 53860000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 100073000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Interest Income: 4745000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 4745000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2067000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 187079000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 4150000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 99692000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Other Payable: 47303000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 45643000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDOBORAX.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment Properties: -30389000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 544111000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 8851000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 8851000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 5669000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1818177000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 42762000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 96622000.00
INDOBORAX.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 507000.00
INDOBORAX.NS balance_sheet (annual, 2022-03-31) — Work In Process: 3618000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — +Operating Expense: 509701000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — +Total Revenue: 2250793000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 34084000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 127912000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -159436000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2720000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 34491000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 32090000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Basic EPS: 15.80
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 358579000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 110695000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -49707000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 327000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 32090000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 852470000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 907746000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -32090000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 813051000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 39419000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 71539000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 20286000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 50100000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Payable: -13635000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -27839000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 102931000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 493891000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Common Stock: 32090000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -32090000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2550519000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 11832000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 1136553000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1683270000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 176031000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Depreciation: 15555000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 15555000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 15539000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 15539000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 32090000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Diluted EPS: 15.80
INDOBORAX.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 506940000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2435000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 46000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — EBIT: 690444000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — EBITDA: 705999000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — End Cash Position: 852470000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -33013000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 5766000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 552840000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -3020000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -17147000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 39623000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 127912000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 335278000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Gross Profit: 1114240000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Interest Expense: 923000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 923000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Interest Income: 23681000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 23681000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -923000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 23681000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Inventory: 578846000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 2550519000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -75643000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 798143000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 34491000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2052000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 327000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 327000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 210699000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income: 506940000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 506940000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 506940000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income Extraordinary: 0.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 506940000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 506940000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 689521000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 506940000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Interest Income: 22345000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: -22023000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -45645000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 22345000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Net PPE: 175842000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -31702000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2550519000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 14388000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 4622000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 678177000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Normalized Income: 486485097.71
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 602547000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Operating Income: 604539000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Operating Revenue: 2250793000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 32090000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 37452000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 139000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -25329000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 27417000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 294329000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Payable: 89660000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Properties: 164010000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 9402000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 55276000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Other Special Charges: -17148000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Payables: 148408000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 0.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 19109000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 16197000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Pretax Income: 689521000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -544000000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment Properties: -22023000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -49707000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 568038000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 1136553000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 15555000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 10588000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 10588000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 5715000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2297159000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 498355000.00
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 18005000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 13911000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 53534000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Share Issued: 32090000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Special Income Charges: 17148000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2550519000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2550519000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 7367097.71
INDOBORAX.NS income_statement (annual, 2023-03-31) — Tax Provision: 182581000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
INDOBORAX.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -159964000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Assets: 2753055000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2550519000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Debt: 327000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2550519000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Total Expenses: 1646254000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 202536000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1069785000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 26505000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 413000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 22229000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 27822000.00
INDOBORAX.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 27822000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Work In Process: 5042000.00
INDOBORAX.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1507239000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — +Operating Expense: 484466000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1913030000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 36360000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 136079000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -182269000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2720000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 39300000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 32080329.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Basic EPS: 12.15
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 852106000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 130509000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -45726000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 326000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 32090000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1214011000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1604593000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -32090000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 1160572000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 53439000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 355007000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 18100000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -16541000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Payable: 2276000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -8167000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 352887000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 361905000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Common Stock: 32090000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -32090000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2934098000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 11252000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1023921000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2013251000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 0.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 0.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 152467000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Depreciation: 22849000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 22849000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 22833000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 22833000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 32090000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Diluted EPS: 12.15
INDOBORAX.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 389776000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2585000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 55000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — EBIT: 522392000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — EBITDA: 545241000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1214011000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -32150000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 1448000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 649511000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -2567000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 27099000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 136079000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 380987000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Gross Profit: 889109000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Interest Expense: 60000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 60000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Interest Income: 60728000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 60728000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -60000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 60728000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Inventory: 223839000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 2934098000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -301182000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 798143000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 39300000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2036000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 326000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 326000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 237190000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income: 389776000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 389776000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 389776000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income Extraordinary: 0.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 389776000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 389776000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 522332000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 389776000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Interest Income: -60000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Net Investment Properties Purchase And Sale: 0.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -316239000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 60451000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Net PPE: 198718000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -45726000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2934098000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 12225000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 56923000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 545241000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Normalized Income: 389776000.00
INDOBORAX.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 695237000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Operating Income: 404987000.00
INDOBORAX.NS income_statement (annual, 2024-03-31) — Operating Revenue: 1913030000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 32090000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 20937000.00
INDOBORAX.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 139000.00